1. Home
  2. AORT vs PLSE Comparison

AORT vs PLSE Comparison

Compare AORT & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AORT
  • PLSE
  • Stock Information
  • Founded
  • AORT 1984
  • PLSE 2014
  • Country
  • AORT United States
  • PLSE United States
  • Employees
  • AORT N/A
  • PLSE N/A
  • Industry
  • AORT Medical/Dental Instruments
  • PLSE Medical/Dental Instruments
  • Sector
  • AORT Health Care
  • PLSE Health Care
  • Exchange
  • AORT Nasdaq
  • PLSE Nasdaq
  • Market Cap
  • AORT 1.2B
  • PLSE 1.1B
  • IPO Year
  • AORT 1993
  • PLSE 2016
  • Fundamental
  • Price
  • AORT $30.66
  • PLSE $18.05
  • Analyst Decision
  • AORT Strong Buy
  • PLSE
  • Analyst Count
  • AORT 5
  • PLSE 0
  • Target Price
  • AORT $31.80
  • PLSE N/A
  • AVG Volume (30 Days)
  • AORT 346.6K
  • PLSE 129.0K
  • Earning Date
  • AORT 02-13-2025
  • PLSE 10-30-2024
  • Dividend Yield
  • AORT N/A
  • PLSE N/A
  • EPS Growth
  • AORT N/A
  • PLSE N/A
  • EPS
  • AORT N/A
  • PLSE N/A
  • Revenue
  • AORT $384,899,000.00
  • PLSE N/A
  • Revenue This Year
  • AORT $12.95
  • PLSE N/A
  • Revenue Next Year
  • AORT $9.76
  • PLSE N/A
  • P/E Ratio
  • AORT N/A
  • PLSE N/A
  • Revenue Growth
  • AORT 13.29
  • PLSE N/A
  • 52 Week Low
  • AORT $16.48
  • PLSE $6.60
  • 52 Week High
  • AORT $32.33
  • PLSE $22.69
  • Technical
  • Relative Strength Index (RSI)
  • AORT 57.21
  • PLSE 49.90
  • Support Level
  • AORT $30.22
  • PLSE $17.18
  • Resistance Level
  • AORT $31.96
  • PLSE $19.90
  • Average True Range (ATR)
  • AORT 1.09
  • PLSE 1.04
  • MACD
  • AORT 0.16
  • PLSE 0.04
  • Stochastic Oscillator
  • AORT 62.90
  • PLSE 35.58

About AORT Artivion Inc.

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others.

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.

Share on Social Networks: